<DOC>
	<DOCNO>NCT00141362</DOCNO>
	<brief_summary>Evaluate long-term safety efficacy pregabalin patient chronic neuropathic pain .</brief_summary>
	<brief_title>Evaluate Long-Term Safety Efficacy Pregabalin Patients With Chronic Neuropathic Pain .</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must meet inclusion criterion precede doubleblind BID study diabetic neuropathy postherpetic neuralgia . Must receive study medication doubleblind condition . Patients participate experience serious adverse event previous doubleblind BID study determine related study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>